Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Computer Cooling Technology To Help Diagnose Digestive Disorders
Some things in life are multi-purpose. Now miniature technology used to cool the central processing units in computers may have found a use in mainstream medicine!
generic viagra online
Fife Council And Contractor Fined ÷£13,700 For Exposing Staff And Public To Asbestos, UK
The Health and Safety Executive (HSE) warned property owners to ensure that they keep accurate records of asbestos in their buildings and pass any information on to contractors.
News of the day
Cephalon Submits NUVIGIL Supplemental New Drug Application For The Treatment Of Excessive Sleepiness Associated With Jet Lag Disorder
Cephalon, Inc. (Nasdaq: CEPH) announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) requesting approval of NUVIGIL(R) (armodafinil) Tablets [C-IV] for the indication of improved wakefulness in patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel. Jet lag disorder is an acute condition that occurs when a person"s internal body clock becomes disrupted as a result of rapid travel across several time zones. Based on U.S. Bureau of Labor Statistics findings, an estimated 70 million American travelers experience jet lag annually. Currently, there are no FDA-approved medications to improve wakefulness in travelers who experience the excessive sleepiness commonly associated with long flights.
Health Insurance

Inovio Biomedical To Present At International DNA Vaccine Conference

Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that it will make multiple presentations at the Annual Conference of DNA Vaccines in Asia 2009 being hosted by the International Society of DNA Vaccines July 9 - 10 at the Beijing International Convention Center. The conference, with the theme, "Advancing DNA Vaccine Technology," is co-chaired by David B. Weiner, Ph.D., professor of pathology, University of Pennsylvania School of Medicine, and chairman of Inovio"s scientific advisory board. Inovio scientists and associates will be making the following presentations: Engineering Highly Immune Potent DNA Vaccines by Engineering Molecular Biology, Immunology and Physical Delivery In Vivo Presidential Address and Keynote Lecture David B. Weiner, Ph.D. Thursday July 9 08:30 - 09:05 Location: 305BC Immune Therapy by Electroporation Plenary Session 2 Iacob Mathiesen, Ph.D., Managing Director, Inovio AS Thursday July 9 11:00 - 12:10 Location: 305BC Pandemic and Seasonal Influenza DNA Vaccines Delivered via Electroporation Plenary Session 3 Niranjan Y. Sardesai, Ph.D., Sr. VP, Research & Development, Inovio Biomedical Thursday July 9 13:10 - 14:55 Location: 305BC Special Considerations for Multi-Component DNA Vaccine Production Plenary Session 7 Henry Hebel, Chief Operating Officer, VGXI Inc. Friday July 10 11:00 - 12:10 Location: 305BC Inovio Biomedical Corporation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009